Advertisement

Index by author

August 01, 2013; Volume 41,Issue 8

A

  1. Andersson, Tommy B.

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

B

  1. Bäckström, Tobias

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

  2. Barrett, Kathleen G.

    1. Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

  3. Beijnen, Jos H.

    1. Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

  4. Bertilsson, Leif

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

  5. Björkhem-Bergman, Linda

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

  6. Bredberg, Eva

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

C

  1. Chang, Shu-Ying

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

  2. Chaudhry, Amarjit S.

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

  3. Choi, Yeon Jae

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  4. Clouser-Roche, Andrea

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

D

  1. Daali, Youssef

    1. Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870

  2. Dayer, Pierre

    1. Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870

  3. de Graaf, Inge A.M.

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  4. de Jager, Marina H.

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  5. de Waard, Hans

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  6. Diczfalusy, Ulf

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

  7. Dinter-Heidorn, Heike

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  8. Doi, Mami

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

E

  1. Edmonds, David J.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  2. Eng, Heather

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

F

  1. Fan, Yiping

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

  2. Fang, Hailin

    1. Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

  3. Fenner, Katherine

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  4. Ferenci, Peter

    1. Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037

  5. Fortin, Jean-Philippe

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  6. Freiwald, Sascha

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  7. Frijlink, Henderik W.

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  8. Fujiyama, Atsushi

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  9. Fukudo, Masahide

    1. Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286

G

  1. Gargano, Mary D.

    1. Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

  2. Ghim, Jong Lyul

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  3. Griffith, David A.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  4. Groothuis, Geny M.M.

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  5. Grubb, Mary F.

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

H

  1. Handa, Makoto

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  2. Hashimoto, Takashi

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  3. Hayeshi, Rose

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  4. Hinrichs, Wouter L.J.

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

I

  1. Ikeda, Yasuo

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  2. Isoherranen, Nina

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

J

  1. Jackson, Margaret

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  2. Jeong, Eun Sook

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

K

  1. Kalgutkar, Amit S.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  2. Katsura, Toshiya

    1. Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286

  3. Kim, Dong-Hyun

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  4. Kim, Hyo-Ji

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  5. Klaassen, Curtis D.

    1. Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
      Matthew Pratt-Hyatt, Andrew J. Lickteig and Curtis D. Klaassen
      Drug Metabolism and Disposition August 2013, 41 (8) 1480-1487; DOI: https://doi.org/10.1124/dmd.113.051904

  6. Kocarek, Thomas A.

    1. Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

  7. Koller, Fabienne

    1. Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037

  8. Konno, Yoshihiro

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  9. Kunimatsu, Sachiko

    1. Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286

L

  1. Lee, Caroline A.

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  2. Lee, Su-Jun

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  3. Li, Xianping

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  4. Lickteig, Andrew J.

    1. Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
      Matthew Pratt-Hyatt, Andrew J. Lickteig and Curtis D. Klaassen
      Drug Metabolism and Disposition August 2013, 41 (8) 1480-1487; DOI: https://doi.org/10.1124/dmd.113.051904

  5. Limberakis, Chris

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

M

  1. Maas-Bakker, Roel F.

    1. Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

  2. Markovich, Daniel

    1. Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

  3. Maruyama, Toru

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  4. Matsuda, Yoshiki

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  5. McDonald, Thomas S.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  6. Meijerman, Irma

    1. Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

  7. Millet, Philippe

    1. Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870

  8. Mizuno, Tomoyuki

    1. Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286

  9. Mooiman, Kim D.

    1. Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

  10. Moret, Ed E.

    1. Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

N

  1. Nagai, Mika

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  2. Nolte, Whitney M.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  3. Nylén, Hanna

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

O

  1. Ogaki, Shigeru

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  2. Okamura, Yosuke

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  3. Otagiri, Masaki

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

P

  1. Pastor, Catherine M.

    1. Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870

  2. Peng, Chi-Chi

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

  3. Pratt-Hyatt, Matthew

    1. Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
      Matthew Pratt-Hyatt, Andrew J. Lickteig and Curtis D. Klaassen
      Drug Metabolism and Disposition August 2013, 41 (8) 1480-1487; DOI: https://doi.org/10.1124/dmd.113.051904

  4. Price, David A.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  5. Proost, Johannes H.

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

R

  1. Reyner, Eric L.

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  2. Rodrigues, A. David

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

  3. Rönquist-Nii, Yuko

    1. Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

  4. Runge-Morris, Melissa

    1. Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

S

  1. Satsukawa, Masahiro

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  2. Schellens, Jan H. M.

    1. Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

  3. Schuetz, Erin G.

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

  4. Seo, Kyung-Ah

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  5. Sevidal, Samantha

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  6. Sharma, Raman

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  7. Shin, Jae-Gook

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  8. Shin, Kye Jung

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  9. Shirasaka, Yoshiyuki

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

  10. Siissalo, Sanna

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

  11. Smith, Bill J.

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  12. Sohn, Dong-Ryul

    1. Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

  13. Stevens, Benjamin D.

    1. Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

  14. Stieger, Bruno

    1. Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037

  15. Strom, Stephen C.

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

T

  1. Taguchi, Kazuaki

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  2. Taguchi, Takayuki

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  3. Takeoka, Shinji

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  4. Thirumaran, Ranjit K.

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

  5. Thummel, Kenneth E.

    1. Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

U

  1. Ujihira, Hayato

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  2. Ullah, Mohammed

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

V

  1. van Dam, Annie

    1. Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

W

  1. Watanabe, Hiroshi

    1. Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

  2. West, Mark A.

    1. In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

  3. Wlcek, Katrin

    1. Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037

Y

  1. Yamashita, Shinji

    1. In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680

  2. Yang, Xia

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

  3. Yasuda, Kazuto

    1. Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
Back to top

In this issue